/study / lectures / Pharmacology
Nitrous Oxide — Pharmacology + Modern Contraindications
TEXTPharmacology · 6 min read
The oldest anesthetic still in use. Inexpensive, low-blood-solubility, profoundly under-appreciated NMDA antagonist — and the source of every closed-air-space problem in the OR.
After this lesson you can
2 min read6 sections- Explain the concentration + second-gas effects.
- Predict closed-air-space expansion and its time course.
- Recall N₂O effects on vitamin B12 + bone marrow.
- Manage diffusion hypoxia at emergence.
Mechanism + MAC
MAC ≈ 104%, meaning you can't reach 1 MAC with N₂O alone at atmospheric pressure — it's an adjunct, not a sole agent.
Concentration effect + second gas effect make it useful for accelerating uptake of volatiles.
Blood:gas partition coefficient 0.47 very fast wash-in + wash-out, but also rapid diffusion into closed spaces.
Closed-space expansion — the major contraindication category
Result: volume expansion in non-compliant cavities (pneumothorax, bowel obstruction, intracranial air, ETT cuff, retinal gas bubble after vitreoretinal surgery — wait 4-6 weeks).
At 50% N₂O inspired, a closed gas space DOUBLES in volume in ~30 minutes; at 75%, it quadruples in similar time.
Stop N₂O 15-20 minutes before ETT cuff volume becomes important (e.g., before extubation in a difficult airway).
Cardiovascular + respiratory
Net effect on BP usually neutral or slightly increased.
Pulmonary vascular resistance rises 10-20%, especially problematic in pulmonary hypertension or right heart failure.
Modest respiratory depression on its own, additive with opioids/volatiles.
Minimal effect on hepatic + renal blood flow.
Toxicity — bone marrow + vitamin B12 + reproductive
Acute single anesthetic: no clinical concern in healthy patient.
Chronic exposure (provider) or prolonged single use (>24 hr, e.g., long ICU sedation): megaloblastic anemia, peripheral neuropathy.
Avoid in patients with documented B12 deficiency, pernicious anemia, or methionine synthase mutations.
Reproductive: NIOSH limits historically restrictive; current data show no demonstrable harm at modern OR concentrations with functioning scavenging.
Diffusion hypoxia at emergence
Prevention: deliver 100% O₂ for 5-10 minutes after stopping N₂O.
Clinically silent in healthy patient; matters in COPD, OSA, obese, or any patient with marginal oxygenation.
Modern role + climate considerations
- mask induction (peds, smell-the-balloon)
- labor analgesia (50:50 N₂O:O₂ via demand valve — Entonox)
- dental + minor procedural sedation
Climate impact: N₂O is 298× the global-warming potential of CO₂ + persists in atmosphere ~120 years.
Many hospitals are phasing out central pipelines + using on-demand cylinders only.
Eliminating N₂O from a system reduces anesthesia GHG footprint substantially.
⚠ Common pitfalls
- Using N₂O in a patient with recent vitreoretinal gas tamponade — 4-6 week hold required.
- Forgetting to deliver 100% O₂ × 5-10 min after stopping N₂O — diffusion hypoxia.
- Long N₂O exposure (>24 hr) in critically ill — B12 oxidation, megaloblastic anemia.
- Using in pneumothorax or bowel obstruction — air space doubles in 30 min at 50% N₂O.
💎 Clinical pearls
- MAC of N₂O is ~104% — it's an adjunct, not a standalone agent at atmospheric pressure.
- Second-gas effect accelerates volatile uptake — concept tested on NBCRNA.
- Cuff volume doubles or more during N₂O cases — deflate to manometer pressure 25 cmH₂O at intervals.
- Climate: N₂O is 298× more potent than CO₂ as a greenhouse gas and persists ~120 yr.
Recap
- MAC of N₂O is ~104% — it's an adjunct, not a standalone agent at atmospheric pressure.
- Second-gas effect accelerates volatile uptake — concept tested on NBCRNA.
- Cuff volume doubles or more during N₂O cases — deflate to manometer pressure 25 cmH₂O at intervals.
- Climate: N₂O is 298× more potent than CO₂ as a greenhouse gas and persists ~120 yr.
Mark each section done to complete the module.
References
- · Stoelting & Hines Pharmacology 6e ch 4
- · Miller's Anesthesia 9e Ch 22 (Inhaled Anesthetics)
- · Nagelhout Nurse Anesthesia 7e (Nitrous Oxide)
- · ASA Greener Operating Room Initiative 2023
- · Sun, Anesth Analg 2007 (B12 + N₂O)
- · ENIGMA-II trial (Lancet 2014) — N₂O safety in cardiac risk